Close

Analyst Ratings for Navidea Biopharmaceuticals (NAVB) [Neutrals]

All Latest Ratings for NAVB

NAVB Rating Summary

  |   Expand Research on NAVB
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 62%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/22/2013 Aegis Capital
» Updated 10/15/2014		 N/A New Coverage Hold
(N/A)		 2.00
(N/A)		 2.97
(0.04)		 -98.65% Details
9/11/2012 ThinkEquity N/A Downgrade Hold
(Buy)		 2.50
(N/A)		 3.51
(0.04)		 -98.86% Details